Paik Kwang Ind (001340) - Total Liabilities
Based on the latest financial reports, Paik Kwang Ind (001340) has total liabilities worth ₩382.49 Billion KRW (≈ $259.21 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Paik Kwang Ind operating cash flow efficiency to assess how effectively this company generates cash.
Paik Kwang Ind - Total Liabilities Trend (2008–2024)
This chart illustrates how Paik Kwang Ind's total liabilities have evolved over time, based on quarterly financial data. Check how resilient are Paik Kwang Ind's assets to evaluate the company's liquid asset resilience ratio.
Paik Kwang Ind Competitors by Total Liabilities
The table below lists competitors of Paik Kwang Ind ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Grupo Industrial Saltillo S.A.B. de C.V
MX:GISSAA
|
Mexico | MX$686.23 Million |
|
Yungjin Pharm Co Ltd
KO:003520
|
Korea | ₩156.23 Billion |
|
TriSalus Life Sciences Inc.
NASDAQ:TLSI
|
USA | $63.19 Million |
|
Jin Air Co Ltd
KO:272450
|
Korea | ₩963.94 Billion |
|
StealthGas Inc
F:S6W
|
Germany | €55.10 Million |
|
Meteoric Resources NL
F:RNF
|
Germany | €8.58 Million |
|
Iron Force Industrial Co Ltd
TW:2228
|
Taiwan | NT$1.98 Billion |
Liability Composition Analysis (2008–2024)
This chart breaks down Paik Kwang Ind's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Paik Kwang Ind (001340) market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.38 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.75 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.64 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Paik Kwang Ind's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Paik Kwang Ind (2008–2024)
The table below shows the annual total liabilities of Paik Kwang Ind from 2008 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩250.87 Billion ≈ $170.01 Million |
+17.64% |
| 2023-12-31 | ₩213.26 Billion ≈ $144.52 Million |
+9.97% |
| 2022-12-31 | ₩193.92 Billion ≈ $131.42 Million |
+14.29% |
| 2021-12-31 | ₩169.67 Billion ≈ $114.98 Million |
+16.60% |
| 2020-12-31 | ₩145.51 Billion ≈ $98.61 Million |
-9.90% |
| 2019-12-31 | ₩161.50 Billion ≈ $109.45 Million |
+12.31% |
| 2018-12-31 | ₩143.79 Billion ≈ $97.45 Million |
-4.01% |
| 2017-12-31 | ₩149.81 Billion ≈ $101.52 Million |
-6.55% |
| 2016-12-31 | ₩160.30 Billion ≈ $108.63 Million |
-26.41% |
| 2011-12-31 | ₩217.82 Billion ≈ $147.61 Million |
+29.12% |
| 2010-12-31 | ₩168.70 Billion ≈ $114.32 Million |
+2.56% |
| 2009-12-31 | ₩164.49 Billion ≈ $111.48 Million |
+18.60% |
| 2008-12-31 | ₩138.70 Billion ≈ $94.00 Million |
-- |
About Paik Kwang Ind
Paikkwang Industrial Co.,Ltd produces and sells inorganic chemical products in South Korea and internationally. It offers caustic soda, hydrochloric acid, liquid chlorine, sodium hypochlorite, and nitrous oxide, as well as nitrogen trifluoride and hydrogen. It also provides D-sorbitol, maltitol syrup, and polyglycitol syrup, as well as re-inspection and internal treatment of high pressure gas cyl… Read more